Alignment Healthcare, Inc. $ALHC Holdings Trimmed by Hennessy Advisors Inc.

01 Jan 2026, 07:14 by Jessica Moore · The Cerbat Gem

Hennessy Advisors Inc. cut its holdings in Alignment Healthcare, Inc. (NASDAQ:ALHC – Free Report) by 7.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 519,700 shares of the company’s stock after selling 41,200 shares during the quarter. Hennessy Advisors Inc. owned about 0.26% of Alignment Healthcare worth $9,069,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. SBI Securities Co. Ltd. raised its holdings in shares of Alignment Healthcare by 4,868.9% in the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after purchasing an additional 2,970 shares in the last quarter. KBC Group NV bought a new stake in Alignment Healthcare during the second quarter worth approximately $44,000. Signaturefd LLC grew its position in Alignment Healthcare by 142.6% in the second quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock worth $53,000 after buying an additional 2,215 shares during the last quarter. Greenleaf Trust bought a new position in shares of Alignment Healthcare in the second quarter valued at $160,000. Finally, Ballentine Partners LLC increased its holdings in shares of Alignment Healthcare by 10.2% in the second quarter. Ballentine Partners LLC now owns 12,862 shares of the company’s stock valued at $180,000 after buying an additional 1,188 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ALHC. JPMorgan Chase & Co. raised their price objective on Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. UBS Group increased their price target on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday, October 31st. The Goldman Sachs Group reissued a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a research note on Monday, November 3rd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.35.

View Our Latest Stock Report on Alignment Healthcare

Alignment Healthcare Trading Up 2.7%

NASDAQ:ALHC opened at $19.75 on Thursday. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61. Alignment Healthcare, Inc. has a fifty-two week low of $11.01 and a fifty-two week high of $21.06. The stock’s 50-day moving average is $18.26 and its two-hundred day moving average is $16.24. The stock has a market cap of $3.95 billion, a PE ratio of -164.58 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last posted its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The business had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same period in the prior year, the firm earned ($0.14) earnings per share. The firm’s revenue was up 43.5% compared to the same quarter last year. As a group, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Hyong Kim sold 12,694 shares of the company’s stock in a transaction on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $237,885.56. Following the transaction, the insider directly owned 349,639 shares of the company’s stock, valued at approximately $6,552,234.86. This represents a 3.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Robert L. Scavo sold 69,541 shares of the stock in a transaction on Monday, December 29th. The stock was sold at an average price of $18.74, for a total value of $1,303,198.34. Following the sale, the insider owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. This represents a 12.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 1,828,297 shares of company stock worth $33,667,738. Insiders own 7.00% of the company’s stock.

Alignment Healthcare News Summary

Here are the key news stories impacting Alignment Healthcare this week:

Positive Sentiment: Baird published a note saying Alignment “should be bought on recent selloff,” a catalyst that can draw value/income buyers and support the stock. Baird Buy Note
Neutral Sentiment: Wall Street sentiment remains broadly constructive — several firms have Buy/Overweight ratings and the consensus target (~$20.35) sits near recent trade levels — which may limit downside if fundamentals stay intact. Analyst Coverage Summary
Negative Sentiment: CEO John E. Kao sold 605,648 shares (~21.3% of his holding) at $18.74 for proceeds of about $11.35M — a large, high‑profile insider sale that can be interpreted negatively by investors. Kao SEC Filing
Negative Sentiment: President Dawn Christine Maroney sold 282,070 shares (~16.9% of her holding) at $18.74 (~$5.29M), another sizable insider disposition that can weigh on sentiment. Maroney SEC Filing
Negative Sentiment: Additional insider sales (Robert L. Scavo: 69,541 shares; Christopher J. Joyce: 16,187; Hyong Kim: 12,694) at the same $18.74 price add to the collective sell signal; combined insider disposals approach ~1M shares on Dec. 29–30. Scavo SEC Filing Joyce SEC Filing Kim SEC Filing

Alignment Healthcare Profile

(Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.